https://doctransparency.com/doctor/tx/houston/asif-ali-1881621993
Medicare Enrolled

Dr. Asif Ali, MD

Cardiovascular Disease · Houston, TX
Practice pattern: Electrophysiology & Cardiac— Practice combining electrophysiology and cardiac services
Speaking/Promotional
8830 LONG POINT RD, Houston, TX 77055
7134644140
In practice since 2006 (19 years)
NPI: 1881621993 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ali from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ali? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ali

Dr. Asif Ali is a cardiovascular disease in Houston, TX, with 19 years in practice. Based on federal Medicare data, Dr. Ali performed 1,240 Medicare services across 869 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ali received a total of $438,965 from 70 pharmaceutical and/or device companies across 1061 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ali is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 1,240 Medicare services$ $438,965 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,240
Medicare services
Bottom 36% in TX for cardiovascular disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
869
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~65 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)441$93$175
Electrocardiogram (EKG), 12-lead285$11$63
Echocardiogram, transthoracic135$150$600
Office visit, established patient (20-29 min)119$72$133
Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan64$69$200
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician62$11$125
New patient office visit (45-59 min)54$118$250
Telephone medical discussion with physician, 11-20 minutes42$69$125
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician24$52$275
New patient office visit (30-44 min)14$59$693
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.9% high complexity
12.1% medium
77.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$438,965
Total received (2018-2024)
Avg $62,709/year across 7 years
Top 1% in TX for cardiovascular disease
70
Companies
1,061
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$338,737 (77.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$80,271 (18.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,957 (4.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$40,386
2023
$46,248
2022
$55,958
2021
$161,413
2020
$42,590
2019
$44,172
2018
$48,198

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$148,962
Lilly USA, LLC
$111,441
PREVENTRIC DIAGNOSTICS, INC.
$78,083
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$61,124
Amgen Inc.
$19,900
Abbott Laboratories
$6,843
Novartis Pharmaceuticals Corporation
$1,077
Janssen Pharmaceuticals, Inc
$872
Medtronic Vascular, Inc.
$623
Boston Scientific Corporation
$583
Cleerly, Inc.
$572
Ablative Solutions, Inc.
$552
PFIZER INC.
$543
ABIOMED
$483
AstraZeneca Pharmaceuticals LP
$464
Actelion Pharmaceuticals US, Inc.
$431
Astellas Pharma US Inc
$419
ARBOR PHARMACEUTICALS, INC.
$374
Lexicon Pharmaceuticals, Inc.
$364
Bardy Diagnostics, Inc.
$335
Novo Nordisk Inc
$293
Merck Sharp & Dohme LLC
$285
Esperion Therapeutics, Inc.
$266
Akcea Therapeutics, Inc.
$250
BOSTON SCIENTIFIC CORPORATION
$248
HEARTFLOW, INC.
$241
Lundbeck LLC
$224
E.R. Squibb & Sons, L.L.C.
$216
Arbor Pharmaceuticals, Inc.
$183
Endologix, Inc.
$182
Impulse Dynamics (USA) Inc.
$171
Gilead Sciences, Inc.
$164
Amarin Pharma Inc.
$164
Baxter Healthcare
$163
Acarix USA Inc.
$147
BIOTRONIK INC.
$147
Merck Sharp & Dohme Corporation
$142
SANOFI-AVENTIS U.S. LLC
$142
Kiniksa Pharmaceuticals, Ltd.
$121
BARD PERIPHERAL VASCULAR, INC.
$113
Medtronic, Inc.
$97
Cardinal Health 200, LLC
$96
Philips Electronics North America Corporation
$89
Azurity Pharmaceuticals, Inc.
$79
IDORSIA PHARMACEUTICALS US INC
$70
Preventice Services, LLC
$54
Surmodics, Inc.
$50
Kiniksa Pharmaceuticals International, plc
$47
Veryan Medical Incorporated
$42
Relievant Medsystems, Inc.
$34
Allergan Inc.
$32
Bolton Medical Inc
$30
Innovation Technologies Inc
$29
Kestra Medical Technology Services, Inc.
$25
iRhythm Technologies, Inc.
$25
Nevro Corp.
$24
GlaxoSmithKline, LLC.
$23
ARALEZ PHARMACEUTICALS US INC.
$22
Althera Pharmaceuticals LLC
$21
MAYNE PHARMA INC.
$21
AGEPHA Pharma FZ LLC
$18
Kowa Pharmaceuticals America, Inc.
$16
Myocardial Solutions, Inc.
$15
CARDIVA MEDICAL, INC.
$15
Noden Pharma USA Inc
$14
CashFlow Solutions, LLC
$14
Edwards Lifesciences Corporation
$14
Regeneron Healthcare Solutions, Inc.
$14
AngioDynamics, Inc.
$14
GENZYME CORPORATION
$13
Top 3 companies account for 77.1% of total payments
Associated products mentioned in payments ›
ASSURITY · Arcalyst · Assure WCD · Assurity Pacemaker · Azure · BELSOMRA · BG Mini Plus · BIOMONITOR · BPRO BT AMBULATORY BLOOD PRESSURE MONITORING SYSTEM · BRILINTA · BYSTOLIC · Bidil · BioMimics 3D Vascular Stent System · BodyGuardian · CADScor System · CARDIOMEMS · CHANTIX · CONFIRM RX · COROFLOW · CRT Leads · CardioMEMS HF System · Carnation Ambulatory Monitor · Cleerly Ischemia · Cleerly Labs · ClosureFast · Confirm Rx · Corlanor · DIAMONDBACK CORONARY · EDARBI · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · Edarbi · Edarbyclor · FABRAZYME · FARXIGA · FFRct · GALLANT · GENERAL TACHY · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · Hillrom - Cardiac Ambulatory Monitor · Hillrom - Carnation Ambulatory Monitor · Horizant · IGT_D Peripheral · IRRISEPT · Impella · Inpefa · Intracept · JANUVIA · JARDIANCE · JOT DX · LATITUDE · LEQVIO · LEXISCAN · LINQ II · LODOCO · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · Lympha Press Optimal Plus(US) BT · MOUNJARO · MULTAQ · Merlin Connectivity and Remote · Mitra Clip system · MitraClip System · NEXLETOL · NORTHERA · OCTRODE · OPSUMIT · OPSUMIT MACITENTAN · Optimizer · Otovel · Ovation · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pounce Thrombectomy System · QUADRA ASSURA · QUARTET · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · Quartet CRT Lead · Repatha · Resolute · Reveal LINQ · Roszet · Rybelsus · STEGLATRO · Senza · Solyx SIS System · TEGSEDI · TEKTURNA · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TRELEGY ELLIPTA · TREO ABDOMINAL STENT-GRAFT SYSTEM · Trilogy 100 · Tryvio · UPTRAVI · VENOVO · VERQUVO · VYNDAQEL · Vascepa · Vascular Closure Device · Veozah · Victoza · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System · ZIO XT Patch · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (77%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for cardiovascular disease in TX.

Equivalent to $35,400 per 100 Medicare services performed
Looking for a cardiovascular disease in Houston?
Compare cardiovascular diseases in the Houston area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
409
Per 100K population
8.6
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN MEMORIAL CITY HOSPITAL
2.2 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ali is a electrophysiology & cardiac specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 1%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ali experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ali performed 441 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ali receive payments from pharmaceutical companies?
Yes. Dr. Ali received a total of $438,965 from 70 companies across 1,061 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ali's costs compare to other cardiovascular diseases in Houston?
Dr. Ali's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ali) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →